Diagnoses in people younger than 55 have nearly doubled since 1995.

According to the American Cancer Society, colorectal cancer is the third-leading cause of cancer-related deaths in men in the United States.

As exciting as full-body MRIs seem, many in medicine are skeptical. But there are useful cases.

Drugmaker Novartis’ Super Bowl ad explained that prostate cancer screening starts with a simple blood test, aiming to dispel fear of an exam for a treatable cancer.

Is the Galleri multi-cancer blood test worth it? A doctor explains real-world performance data and explains why no major medical society recommends the test for screening.

If proven effective in humans, the vaccine could complement standard therapies for HPV-driven cancer, as well as inform the design of therapeutic vaccines for other diseases.

Cameron Mathison celebrates six years cancer free and shares how paying attention to his body saved his life after kidney cancer diagnosis in 2019.

A gene therapy that patients breathe in has been found to shrink lung tumours by inserting immune-boosting genes into surrounding cells

Annie Barron told Newsweek it was such an emotional moment when she got to ring the bell for her 11-year-old vizsla.

The National Cancer Institute, the federal research agency charged with leading the war against the nation's second-largest killer, is studying ivermectin as a potential cancer treatment, according to its top official.